Aldeyra Therapeutics Inc (ALDX)
SG&A Expenses
$1.14T
TTM · Period ending: · USD

ALDX SG&A Expenses
Latest reported$1.14Tperiod ending
Latest reported$1.14Tperiod ending
ALDX TTM SG&A Expenses ($2.13M → $1.14T)
TTM SG&A Expenses
High-resolution chart · PNG
ALDX sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 1,137,350,300,705 | |
| 1,137,349,598,215 | |
| 9,602,350 | |
| 9,185,765 | |
| 10,311,457 | |
| 11,686,018 | |
| 11,892,240 | |
| 11,743,984 | |
| 10,636,618 | |
| 10,978,304 | |
| 13,335,363 | |
| 16,271,186 | |
| 16,927,421 | |
| 16,691,951 | |
| 15,373,922 | |
| 13,201,446 | |
| 12,503,317 | |
| 12,427,689 | |
| 11,283,004 | |
| 11,225,154 | |
| 10,933,964 | |
| 10,085,315 | |
| 9,985,454 | |
| 10,694,392 | |
| 11,278,094 | |
| 12,174,505 | |
| 12,154,702 | |
| 11,486,771 | |
| 11,713,364 | |
| 10,970,009 | |
| 9,876,274 | |
| 8,831,520 | |
| 7,241,512 | |
| 6,350,245 | |
| 6,185,820 | |
| 5,890,399 | |
| 5,811,229 | |
| 5,791,664 | |
| 5,520,345 | |
| 5,541,053 | |
| 5,405,515 | |
| 4,898,167 | |
| 4,414,709 | |
| 4,195,530 | |
| 3,706,801 | |
| 3,734,501 | |
| 3,563,046 | |
| 3,388,057 | |
| 3,116,006 | |
| 2,794,067 | |
| 2,134,726 | |
| 1,322,615 |